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Hypholoma lateritium (Schaeff.) P. Kumm., brick cap by its vernacular name, is a 
basidiomycetes species, member of the Strophariaceae family. It is a saprobic 
macrofungus native to Europe,  North America and the Far East, occurring usually in 
small tufts or occasionally singly on hardwood stumps. Previous mycochemical studies 
reported the presence of sesquiterpenoids, ergostane and lanostane triterpenes with 
cytotoxic activity. 
In this study we aimed to investigate the anti-inflammatory properties of H. lateritium 
extracts, as well as to identify the characteristic secondary metabolites which may 
contribute to the beneficial pharmacological properties of this mushroom. In this view 
organic (n-hexan, chloroform and 50% methanol) and water extracts of H. lateritium 
and six fasciculol type steroids isolated from this species  were subjected to 3 different 
in vitro assays focusing on COX-2 inhibition, and production of cPGES and Nrf2, 
respectively. Significantly decreased expression of cyclooxygenase-2 (COX-2) and 
increased synthesis of PGE3 and Nrf2 were observed for exracts, as well as for the 
steroids of this species. The results obtained demonstrate that extracts of brick cap 
mushroom and its isolated steroids exert not only significant inhibitory activity on COX-
2, but they are also capable to stimulate the Nrf2 pathway. Our study furnishes 
experimental evidence that Hypholoma lateritium has notable anti-inflammatory 
properties which can be explored in future studies in the view of potential medical 
application. 
 
 
Acknowledgements 
Financial support from the Economic Development and Innovation Operative Program GINOP-2.3.2-15-2016-
00012 is gratefully acknowledged. Grant 20391-3/2018/FEKUSTRAT awarded by the Ministry of Human 
Capacities, Hungary, is acknowledged. A. Ványolós is grateful for the grant of the Hungarian National Research, 
Development and Innovation Fund (PD 124476). 
  
